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The growing incidence of multidrug-resistant (MDR) bacteria is an emerging challenge in
modern medicine. The utility of carbapenems, considered “last-line” agents in therapy
of infections caused by MDR pathogens, is being diminished by the growing incidence
of various resistance mechanisms. Enterobacter cloacae have lately begun to emerge
as an important pathogen prone to exhibiting multiple drug resistance. We aimed to
investigate the molecular basis of carbapenem-resistance in 44 E. cloacae clinical strains
resistant to at least one carbapenem, and 21 susceptible strains. Molecular investigation
of 65 E. cloacae clinical strains was based on quantitative polymerase chain reaction
(qPCR) allowing for amplification of ampC, ompF, and ompC transcripts, and analysis of
nucleotide sequences of alleles included in MLST scheme. Co-operation of three distinct
carbapenem resistance mechanisms has been reported—production of OXA-48 (5%),
AmpC overproduction (97.7%), and alterations in outer membrane (OM) transcriptome
balance. Carbapenem-resistant E. cloacae were characterized by (1.) downregulation
of ompF gene (53.4%), which encodes protein with extensive transmembrane channels,
and (2.) the polarization of OM transcriptome-balance (79.1%), which was sloped toward
ompC gene, encoding proteins recently reported to possess restrictive transmembrane
channels. Subpopulations of carbapenem-susceptible strains showed relatively high
degrees of sequence diversity without predominant types. ST-89 clearly dominates
among carbapenem-resistant strains (88.6%) suggesting clonal spread of resistant
strains. The growing prevalence of pathogens resistant to all currently available
antimicrobial agents heralds the potential risk of a future “post-antibiotic era.” Great
efforts need to be taken to explore the background of resistance to “last resort”
antimicrobials.
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INTRODUCTION
An enormous adaptive capacity of Gram-negative multidrug-resistant (MDR) bacteria enables
them to accumulate many different mechanisms of resistance to various antimicrobial agents
(Nikaido, 2009; Poole, 2011). As a result occurrence of MDR pathogens considerably reduces the
opportunities for an effective treatment of infectious diseases (Kaye and Pogue, 2015). Another
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vital epidemiological problem is the emergence and spread of
novel mechanisms of antimicrobial drug resistance, especially
among subpopulations of pathogens persisting in hospital
environments (Hawkey and Jones, 2009; Davin-Regli and Pagès,
2015). The prevalence of those highly resistant microorganisms
contributes significantly to prolonged hospitalization and
increased mortality (Cerceo et al., 2016; MacVane, 2017).
Increasing drug resistance among bacteria forces us to search
for new therapeutic solutions and make decisions beyond
standard treatment patterns (Fischbach, 2011; Tamma et al.,
2012; Khameneh et al., 2016). However, the growing prevalence
of pathogens resistant to most or even all currently available
antimicrobial agents heralds the potential risk of a future “post-
antibiotic era” (Falagas and Bliziotis, 2007; Majewski et al.,
2012). According to the estimates published in a UK report on
the development of antimicrobial resistance, in 2050, infections
caused by MDR microorganisms could become one of the most
important causes of mortality worldwide (10 million deaths per
year), surpassing even the mortality rate currently caused by
cancer (8.2 million deaths per year) (Review on Antimicrobial
Resistance, 2014).
Carbapenems, broad spectrum agents with high bactericidal
activity, are often referred to as “drugs of last resort” that
retain activity against MDR Gram-negative bacteria (Papp-
Wallace et al., 2011). However, the utility of carbapenems
is being diminished by the growing incidence of various
resistance mechanisms in bacteria (Giamarellou, 2010;
Karaiskos and Giamarellou, 2014; Tängdén and Giske,
2015). Most frequently, carbapenem-resistance among
Enterobacteriaceae is the result of various interacting β-
lactam resistance strategies—namely, production of acquired
carbapenemases, alteration in OM permeability, significantly
increased production of chromosomally encoded β-lactamases
(with slight carbapenemase activity, i.e., AmpC), and/or active
eﬄux (Papp-Wallace et al., 2011). E. cloacae have lately begun to
emerge as an important pathogen prone to exhibiting multiple
drug resistance mechanisms and represents particularly high
risk in the healthcare setting (Davin-Regli and Pagès, 2015).
Therefore, we aimed to investigate the molecular basis of
carbapenem-resistance in clinical strains of E. cloacae. Molecular
characterization was based on qPCR, which was utilized in
order to determine influence of chromosomal cephalosporinase
(ampC) and porin-encoding (ompF, ompC) genes transcription
level on carbapenem-resistance.
MATERIALS AND METHODS
Identification, Susceptibility Testing, and
Resistance Detection
This study aimed to investigate the molecular basis of
carbapenem resistance in 44 E. cloacae clinical strains resistant
to at least one carbapenem, and 21 susceptible strains. Pathogens
originated from patients hospitalized between 2007 and 2015
in University Hospital and the Children’s University Hospital
of Bialystok. Biochemical identification was performed using
ID-GN cards and automated the VITEK2 system (bioMérieux,
Marcy l’Etoile, France) following manufacturer’s guidelines.
Antimicrobial activity of carbapenems (ertapenem, meropenem,
imipenem, doripenem, biapenem) and cephalosporins (cefepime,
cefotaxime, ceftazidime, ceftriaxone) was investigated with
the use of the microdilution method in Mueller-Hinton
Broth (Oxoid, Basingstoke, UK). Results were interpreted in
accordance with the European Committee on Antimicrobial
Susceptibility Testing (EUCAST) (The European Committee
on Antimicrobial Susceptibility Testing, 2015). Synergy testing
of carbapenems (meropenem and imipenem) with β-lactamase
inhibitors, double-disk synergy test for extended-spectrum β-
lactamase (ESBL) screening (Mueller-Hinton with and without
cloxacillin), and a biochemical carbapenemase assay (CARBA-
NP test II) were performed, as described previously (Dortet
et al., 2012). Polymerase chain reaction (PCR) experiments
were done in order to detect various carbapenemase-encoding
genes. Oligonucleotides and thermal conditions are presented in
Table 1.
Analysis of Gene Expression Patterns
Overnight cultures of E. cloacae isolates on Luria Broth (A&A
Biotechnology, Gdynia, Poland) were centrifuged and subjected
to total RNA isolation procedure (Total RNA Mini Plus,
A&A Biotechnology, Gdynia, Poland). Traces of DNA were
removed with the use of DNase and silica columns (Clean-
Up RNA Concentrator, A&A Biotechnology). Quantity of total
RNA extracts was examined with the use of spectrophotometer
(NanoDropTM 2000, Thermo Fisher Scientific, Waltham, USA).
Synthesis of cDNA was performed with the use of 1.0µg of
total RNA, 200U of SuperScript R© IV reverse transcriptase, 4µl
of concentrated Super-Script buffer (Thermo Fisher Scientific,
Waltham, USA), 100µM of deoxynucleotide triphosphates
(dNTPs), 50µM of random hexamers, 40U of RNase inhibitor
and 100µM of dithiothreitol (DTT) (A&A Biotechnology).
Real-time quantitative PCR was performed using SYBR R©
Green I assay with analysis of dissociation curve (Real-
Time 2xPCR Master Mix SYBR C, A&A Biotechnology)
on an MxPro 3005P thermal cycler (Agilent Technologies,
Waldbronn, Germany). Oligonucleotides and thermal conditions
are presented in Table 1. Efficiency of particular reactions were
established by standard curve method. Results were calculated by
efficiency corrected method described by Pfaﬄ (2001). Analysis
of mRNA levels was carried out in triplicate. Moreover, the
Liquid Handling Robot QIAgility (Qiagen, Hilden, Germany)
was utilized to set up real-time quantitative PCR. E. cloacae
ATCC 700323 (CL7094, Oxoid Culti-Loops R©, Basingstoke, UK)
was used as a reference in the analysis of relative changes in gene
expression.
During the analysis of relative changes in gene expression
level, a logarithmic transformation of fold changes (FC—fold
change) was applied for statistical purposes. Quantitative
(FC) and categorical data were utilized to assess differences
between carbapenem-resistant and carbapenem-susceptible
subpopulations. For the purpose of categorization in the analysis
of relative increase of AmpC β-lactamase expression level,
a threshold of log2FC ≥ 2.0 was adopted. For the purpose
of qualitative directional analysis of relative changes in OM
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TABLE 1 | Oligonucleotides used in polymerase chain reactions.
Oligonucleotide Sequence (5′–3′) Product Application References
OXA−48−like_F ATC ACA GGG CGT AGT TGT GC 182 bp PCR This study
OXA−48−like_R GCG TCT GTC CAT CCC ACT TA
NMC-A/IMI_F CAA TGG CAG GAT TGG TGT CT 412 bp PCR This study
NMC-A/IMI_R CTC ATC GCC TGG AAT AGC TG
OXA-51-like_F GGA AGT GAA GCG TGT TGG TT 224 bp PCR This study
OXA-51-like_R CCC AAC CAC TTT TTG CGT AT
OXA-58-like_F AAT TGG CAC GTC GTA TTG GT 231 bp PCR This study
OXA-58-like_R CCC CTC TGC GCT CTA CAT AC
GES_F CGA AAA AGC AGC TCA GAT CG 184 bp PCR This study
GES_R GTC CGG CCC ATA TGA AAG TT
VIM_F GAT GGT GTT TGG TCG CAT A 390 bp PCR Ellington et al., 2007
VIM_R CGA ATG CGC AGC ACC AG
KPC_F ATG GCC GCT GGC TGG CTT TT 785 bp PCR Sacha et al., 2012
KPC_R CGG CCT CGC TGT GCT TGT TCA
IMP_F GGA ATA GAG TGG CTT AAY TCT C 188 bp PCR Ellington et al., 2007
IMP_R CCA AAC YAC TAS GTT ATC T
NDM_F GAC CGA TGA CCG CCC AG 372 bp PCR Findlay et al., 2012
NDM_R GAC TTG GCC TTG CTG TCC TT
ampC_F CTC ACT TAA GCA GGG CAT CG 167 bp qPCR This study
ampC_R TCA CTT CTA CCA CGG GCA AC
ompF_F GAC GCA GGC TCC TTC GAC TA 172 bp qPCR This study
ompF_R CAA CCA GGC CGA AGA AGT TG
ompC_F CTA CGG CGT TGT TTA CGA TGT G 150 bp qPCR This study
ompC_R AGA CCA TCA ACC AGA CCG AAG A
rpoB_F TCC ACT CAT GAC GGA CAA CG 170 bp qPCR This study
rpoB_R GCC ATG AAC CAC GGT AAG GA
Detection of carbapenemase-encoding genes was carried out in the following thermal conditions—5 min of initial denaturation at 95◦C, 30 cycles of denaturation at 95◦C for 15 s,
annealing at 55◦C for 30 s, and elongation at 72◦C for 30–40 s, followed by final elongation at 72◦C for 5 min; Analysis of mRNA levels was carried out with the following thermal
conditions—5 min of initial denaturation at 95◦C, 35 cycles of denaturation at 95◦C for 15 s, annealing at 55◦C for 30 s, and elongation at 72◦C for 30 s, followed by analysis of melting
profiles of obtained products.
protein-encoding genes, three ranges of values were adopted: (1)
log2FC ≤ −1.0 for relatively increased expression level, (2)
log2FC ≥ 1.0 for relatively decreased expression level, and
(3) log2FC ranging from −1.0 to 1.0 for relatively indifferent
expression level.
OM transcriptome profiles of tested strains were established
after the interpretation of relative changes in porin-encoding
gene expression level, in accordance with accepted thresholds.
OM transcriptome profiles were created in order to illustrate the
relationship between the transcript level of two major porins and
the phenotype. Nine possible OM transcriptome variants were
adopted (Table 2).
Polarization index (PI—quotient of FCompF and FCompC) was
developed for the quantitative measurement of OmpC-directed
OM transcriptome polarization which could have a potential
link to the development of resistance to β-lactams. Polarization
index differences between groups were proven to be statistically
significant (Table 3, p = 0.0001). Moreover, the interplay
between OmpC-directed OM transcriptome polarization and
overexpression of AmpC β-lactamase, as well as its influence on
susceptibility patterns was estimated by derivative derepression-
polarization index (DPI − log2FCampC + log2PI). Correlation
betweenMIC values of carbapenems and DPI values was assessed
by the Pearson correlation test (Figure 1, p < 0.05).
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TABLE 2 | Distribution of OM transcriptome profile among E. cloacae
strains.
OM transcriptome profile Polarization CARB−R CARB−S
n [%] n [%]
ompF (↓):ompC(↓) (I) – 1 2.3 1 4.8
ompF (↓):ompC(↑) (II) OmpC 11 25.6 1 4.8
ompF (↓):ompC(–) (III) OmpC 11 25.6 2 9.5
ompF (–):ompC(↑) (IV) OmpC 12 27.9 4 19
ompF (–):ompC(↓) (V) OmpF 3 7.0 4 19
ompF (–):ompC(–) (VI) – 4 9.3 6 28.6
ompF (↑):ompC(↓) (VII) OmpF 0 0 2 9.5
ompF (↑):ompC(↑) (VIII) – 1 2.3 0 0
ompF (↑):ompC(–) (IX) OmpF 0 0 1 4.8
OM transcriptome profiles of tested strains were established after the interpretation of
relative changes in porin-encoding gene expression level, in accordance with accepted
thresholds.
Strain Typing
Investigation of genetic relatedness was performed according to
multi-locus sequence analysis scheme developed by Miyoshi-
Akiyama et al. (2013). Analysis of nucleotide sequences was
undertaken using Sanger sequencing (BrightDyeTM Terminator
Sequencing Kit, Nimagen, Nijmegen, Netherlands) and
subsequent capillary electrophoresis using the 3500 Genetic
Analyzer (Applied Biosystems, Foster City, USA). Any novel
alleles or sequence types (STs) were assigned and stored in
the PubMLST domain (http://pubmlst.org). Phylogenetic
analysis with the use of concatenated sequences and maximum
parsimony method (BioNumerics 7.6—evaluation license,
Applied Maths, Sint-Martens-Latem, Belgium) were utilized to
determine the degree of relatedness between particular strains of
E. cloacae.
RESULTS
Antimicrobial susceptibility testing of 65 clinical strains of E.
cloacae was performed with the use of the broth microdilution
method (Table 4). Pathogens were divided into two groups
according to their susceptibility—44 E. cloacae clinical strains
resistant to at least one carbapenem (CARB-R), and 21
susceptible strains (CARB-S). The range of obtained MICs of
particular antimicrobial agents was illustrated by MIC50 and
MIC90 values. Descriptive statistics considering antimicrobial
susceptibility testing are presented in Table 5.
Phenotypic double-disk synergy test revealed similar rates of
ESBL occurrence in both carbapenem-resistant (41%, n = 18)
and carbapenem-susceptible (48%, n = 10) subpopulations of
clinical E. cloacae strains (Table 6). Synergy testing with the use
of carbapenemase inhibitors was negative for all tested E. cloacae
clinical strains. However, the CARBA-NP II biochemical assay
revealed carbapenemase activity in two carbapenem-resistant
strains (5%, n = 2), particularly R3 and R4. PCR and Sanger
sequencing enables us to classify carbapenemase as a class
D enzyme, namely OXA-48 in both carbapenemase-positive
strains.




1 R1 102.6 33 R35 3.8
2 R2 2.4 34 R36 5.7
3 R3 7.7 35 R37 3.3
4 R5 0.5 36 R38 3.6
5 R6 2.7 37 R39 6
6 R7 0.4 38 R40 9
7 R8 12 39 R41 4
8 R9 5.7 40 R42 5.3
9 R10 6.3 41 R43 3
10 R11 12.5 42 R44 2.4
11 R12 11.7 43 R69 9.6
12 R13 24 44 S45 6.5
13 R14 6.5 45 S46 12.5
14 R15 8.5 46 S47 2.4
15 R16 15.5 47 S48 1.1
16 R17 20.8 48 S49 0.6
17 R18 34.1 49 S52 2.1
18 R19 2.1 50 S53 0.01
19 R20 6.5 51 S54 0.01
20 R21 1.2 52 S55 2.3
21 R22 2.8 53 S56 0.003
22 R23 1.6 54 S57 1.7
23 R24 23 55 S58 0.7
24 R25 53.7 56 S59 0.8
25 R26 1.6 57 S61 0.9
26 R28 3 58 S62 16.3
27 R29 0.5 59 S63 0.5
28 R30 1.6 60 S64 1.2
29 R31 3.6 61 S65 0.9
30 R32 0.6 62 S66 2.7
31 R33 5.5 63 S67 0.1
32 R34 10 64 S68 1.4
In the following step, an analysis of relative changes in
the expression levels of genes encoding general OM proteins
responsible for β-lactam penetration (ompC and ompF) as well
as chromosomal AmpC β-lactamase was performed. Numerical
data illustrating directional relative changes in gene expression
levels are presented in Table 6.
Relative changes in the blaampC transcript levels in the
examined E. cloacae subpopulations were unidirectional.
Most pathogens from the CARB-R subpopulation (97.7%)
showed derepression of chromosomal class C β-lactamase.
Carbapenemase-producing E. cloacae R4 was the only
nonderepressed strain accounted for in the carbapenem-
resistant group. The range of log2FCampC values in the CARB-R
group was between 10.0 and 0.2, with a median value at 4.35. In
the CARB-S subpopulation, reported relative changes in ampC
gene expression fell within a range of 3.0–0.4, with a median
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FIGURE 1 | Correlation between derepression-polarization index (DPI) and MICs among E. cloacae strains. Correlations between log-transformed MIC
values and DPI were assessed with use of Pearson correlation test.
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TABLE 4 | MIC values (mg/L) of β−lactams against the clinical E. cloacae
strains.
ETP IMP MEM DOR BIA CAZ FEP CTX TRX
R1 128 8 16 8 8 512 32 512 2048
R2 32 4 16 4 4 512 256 1024 2048
R3 64 4 4 4 1 8 256 512 512
R4 16 2 4 1 0.25 4 256 256 512
R5 32 4 8 2 2 128 512 2048 2048
R6 64 4 8 4 4 256 512 2048 4096
R7 32 2 2 1 1 256 32 1024 2048
R8 8 0.25 0.5 0.25 0.25 512 32 1024 4096
R9 8 0.5 1 0.25 0.125 256 128 1024 2048
R10 8 0.5 0.25 0.125 0.125 256 64 1024 2048
R11 8 0.5 0.5 0.25 0.125 256 128 1024 2048
R12 8 0.5 1 0.5 0.25 256 128 1024 2048
R13 128 8 8 4 4 512 64 1024 4096
R14 8 0.5 1 0.25 0.125 256 32 512 2048
R15 16 1 4 1 1 512 64 1024 4096
R16 8 0.5 0.5 0.25 0.125 512 256 1024 4096
R17 32 2 2 0.5 0.25 512 16 1024 2048
R18 8 0.5 0.5 0.5 0.125 128 8 256 1024
R19 4 0.25 0.25 0.125 0.06 128 16 256 512
R20 8 0.5 0.5 0.5 0.5 512 32 2048 4096
R21 16 1 4 1 1 512 32 1024 2048
R22 8 1 1 0.25 0.125 512 128 1024 2048
R23 8 0.5 0.5 1 0.25 256 128 512 1024
R24 8 0.5 0.5 0.25 0.25 256 32 512 1024
R25 8 1 1 2 1 1024 64 2048 4096
R26 4 0.25 0.25 0.25 0.125 128 8 512 1024
R28 2 0.25 0.125 0.125 0.125 256 32 512 1024
R29 2 0.25 0.125 0.125 0.125 128 128 256 512
R30 8 0.5 0.5 0.25 0.25 128 8 512 1024
R31 8 0.5 0.5 0.5 0.125 256 128 1024 2048
R32 8 0.5 0.25 0.25 0.25 64 16 512 1024
R33 8 0.5 0.25 0.25 0.25 256 16 512 1024
R34 8 0.5 0.25 0.25 0.125 256 128 512 2048
R35 4 0.5 0.25 0.25 0.125 256 32 512 1024
R36 4 0.25 0.25 0.25 0.125 512 16 512 1024
R37 2 0.25 0.125 0.5 0.5 256 64 512 2048
R38 8 0.5 0.5 0.5 0.5 512 64 1024 4096
R39 4 0.25 0.25 0.125 0.125 256 8 512 1024
R40 4 1 0.5 0.25 0.5 256 16 512 1024
R41 4 0.25 0.5 0.25 0.5 256 32 512 1024
R42 4 0.25 1 0.25 0.125 256 32 512 2048
R43 2 0.25 0.25 0.125 0.125 256 512 2048 4096
R44 8 0.5 0.5 0.5 0.5 512 64 1024 2048
R69 4 0.5 0.25 0.25 0.25 256 32 512 512
S45 0.06 0.25 0.06 0.03 0.03 0.25 0.125 0.25 0.5
S46 0.125 0.06 0.125 0.03 0.03 32 64 512 512
S47 0.5 0.25 0.06 0.03 0.06 64 16 512 1024
S48 0.5 0.25 0.03 0.06 0.06 128 1 8 8
S49 0.06 0.25 0.015 0.03 0.06 64 32 1024 1024
S52 0.03 0.25 0.015 0.03 0.06 8 64 2048 1024
(Continued)
TABLE 4 | Continued
ETP IMP MEM DOR BIA CAZ FEP CTX TRX
S53 0.008 0.125 0.015 0.03 0.03 0.25 0.125 0.125 0.125
S54 0.008 0.25 0.015 0.06 0.03 0.06 0.125 0.06 0.125
S55 0.015 0.25 0.015 0.03 0.06 0.25 0.125 0.125 0.25
S56 0.008 0.25 0.015 0.03 0.03 0.5 0.125 0.25 0.5
S57 0.03 0.25 0.03 0.03 0.06 0.5 0.25 1 0.5
S58 0.25 0.25 0.06 0.06 0.06 1 0.125 1 16
S59 0.03 0.25 0.03 0.03 0.03 0.125 0.125 0.125 0.25
S61 0.25 0.25 0.06 0.03 0.03 2 32 128 256
S62 0.06 0.06 0.015 0.03 0.03 0.5 0.25 0.5 1
S63 0.5 0.5 0.125 0.125 0.06 128 1 16 16
S64 0.5 0.25 0.125 0.06 0.06 2 0.25 4 4
S65 0.03 0.125 0.03 0.03 0.03 256 4 32 64
S66 0.5 0.25 0.125 0.06 0.06 256 1 32 64
S67 0.125 0.25 0.03 0.06 0.06 16 0.125 16 16
S68 0.03 0.25 0.03 0.03 0.03 0.125 0.125 0.25 0.25
ETP, ertapenem; IMP, imipenem; MEM, meropenem; DOR, doripenem; BIA, biapenem;
CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; TRX, ceftriaxone; Presented data is
expressed in in mg/L.
value of 0.73. Analysis of relative changes in ampC expression
level showed statistically significant variation between CARB-R
and CARB-S subpopulations (p < 0.000001).
During the analysis of relative changes in transcript levels
(ompF and ompC) among tested E. cloacae strains, bidirectional
changes were reported. Strain R4 was excluded from OM
transcript level analysis due to lack of ompF, and ompC
amplification, despite the confirmed oligonucleotide specificity
on gDNA of all tested strains. Most of the CARB-R strains
showed relative decrease in ompF expression level (53.4%).
Interestingly, strains exhibiting a decrease in ompF expression
level were present also in the CARB-S subpopulation (19%),
although these pathogens did not develop simultaneous AmpC
derepression. The range of log2FCompF values in the CARB-R
group was between −2.18 and 5.68, with a median value at
1.03. In the CARB-S subpopulation, reported relative changes
in ompC gene expression fell within a range of −3.15 to 4.02,
with a median value of 0.23. Analysis of relative changes in
ompF gene expression showed statistically significant differences
between tested E. cloacae subpopulations (p < 0.0006). The
relative decrease in ompC expression was present with much
stronger frequency in CARB-S (33.3%), as compared to CARB-
R (9%). However, most of the CARB-R strains (55.8%) were
characterized by relatively increased ompC gene expression level.
The range of log2FCompC values in the CARB-R group was
between −3.19 and 2.15, with a median value at −1.03. In the
CARB-S subpopulation, reported relative changes in ompC gene
expression level fell within a range of −2.39 to 7.22, with a
median value of 0.06. Analysis of relative changes in ompC gene
expression showed statistically significant differences between
tested E. cloacae subpopulations (p < 0.008).
Nine OM transcriptome profiles created in order to illustrate
the relationship between the transcript level of two major
porins and the phenotype are presented in Tables 5, 6. OM
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TABLE 5 | Descriptive statistics considering antimicrobial susceptibility of
tested Enterobacter cloacae strains.
Group Agent Range Median Mode MIC50 MIC90
CARB−R ETP 2–128 8 8 32 8
IMP 0.25–8 0.5 0.5 4 0.5
MEM 0.125–16 0.5 0.5 8 0.5
DOR 0.125–8 0.25 0.25 4 0.25
BIA 0.06–8 0.25 0.125 2 0.25
CAZ 4–1024 256 256 512 256
FEP 8–512 48 32 256 32
CTX 256–2048 512 512 2048 512
TRX 512–4096 2048 2048 4096 2048
CARB−S ETP 0.008–0.5 0.06 0.03 0.5 0.06
IMP 0.06–0.5 0.25 0.25 0.25 0.25
MEM 0.008–0.125 0.03 0.015 0.125 0.03
DOR 0.03–0.125 0.03 0.03 0.06 0.03
BIA 0.03–0.06 0.045 0.06 0.06 0.06
CAZ 0.06–256 1.5 0.25 256 2
FEP 0.125–64 0.25 0.125 64 0.25
CTX 0.06–2048 2.5 0.125 512 1
TRX 0.125–1024 6 0.25 1024 4
ETP, ertapenem; IMP, imipenem; MEM, meropenem; DOR, doripenem; BIA, biapenem;
CAZ, ceftazidime; FEP, cefepime; CTX, cefotaxime; TRX, ceftriaxone; Presented data is
expressed in in mg/L.
transcriptome profiles II, III, and IV with ompC-directed
polarization (narrow transmembrane channel) were
characteristic for the CARB-R subpopulation and constituted
a total of 79.1%. In CARB-S strains OM transcriptome profiles
V, VII, and IX with ompF-directed polarization accounted
for 33.3%. Profile VI with unaltered levels of both porin-
encoding genes was assigned for 28.6% of CARB-S strains.
Polarization indices representing quantitative measurement
of OmpC-directed OM transcriptome polarization, which
could have a potential link to the development of resistance to
β-lactams, are presented in Table 3 (p = 0.0001). Moreover,
the interplay between OmpC-directed OM transcriptome
polarization and overexpression of AmpC β-lactamase, as
well as its influence on MIC values estimated by derivative
derepression-polarization index (DPI − log2FCampC +
log2PI). Correlations between MIC and DPI values assessed
by the Pearson correlation test are presented in Figure 1
(p < 0.05).
Phylogenetic analysis with the use of concatenated sequences
andmaximumparsimonymethod showed a degree of relatedness
between particular strains of E. cloacae (Figure 2, Table 6).
A group of CARB-S strains was characterized by a high
diversity of STs, among which we failed to specify the dominant
group. Carbapenem-susceptible strains were assigned to ST-133
(14.3%), ST-335, ST-45, ST-108, ST-168 (9.5%), and single cases
of ST-752, ST-753, ST-754, ST-110, ST-79, ST-407, ST-68, ST-
89, and ST-90 (1.9%). Among CARB-R E. cloacae strains, we
observed a clearly dominating ST-89 (88.6%), suggesting clonal
spread of carbapenem-resistant pathogens among patients of the
University Hospital and the University Children’s Hospital of
Bialystok. The remaining strains of CARB-R E. cloacae belonged
to the individual, relatively closely related ST-751 and ST-329
(2.3%); more distant types ST-750 and ST-121, as well as ST-
186, located far away from the entire pool of tested E. cloacae
strains.
DISCUSSION
We identified three distinct mechanisms that may contribute
to the phenotype of resistance to carbapenems among tested E.
cloacae subpopulations. A unique mechanism in the performed
analysis was identified in two CARB-R strains (5%). Two
exceptional strains, R3 and R4, possess the ability to produce
acquired OXA-48 carbapenemase. The presence of OXA-48-
type carbapenemase in E. cloacae is not a phenomenon widely
described in the literature. Strain R3 was the first case of OXA-
48 carbapenemase-producing E. cloacae infection in Poland
(Majewski et al., 2014a).
In the remaining part of the CARB-R E. cloacae
subpopulation, we observed the coexistence of two distinct
mechanisms of resistance related to β-lactams: overproduction
of AmpC cephalosporinase, and alterations in the expression
profile of porin-encoding genes. Constitutive overproduction of
the chromosomal AmpC cephalosporinase was typical for most
CARB-R strains (97.7%). The exceptional strain R4 expressed
inducible AmpC, and was also capable of producing OXA-48
carbapenemase. Strains belonging to the CARB-S control group
were able to produce AmpC cephalosporinase at low level
(90.4%), except for two strains, S53 and S54 (see explanation
below).
The second mechanism associated with the development of
resistance to carbapenems in tested E. cloacae subpopulations
is alterations in the OM transcriptome profile responsible for
permeability of the OM. A large percentage of carbapenem-
resistant strains (53.4%) were characterized by a relative
decrease in the expression level of ompF, gene encoding
an protein essential for efficient β-lactam penetration into
periplasmic space (Delcour, 2009; James et al., 2009; Ziervogel
and Roux, 2013). Another trend identified in the CARB-R
group was the altered balance of OM transcriptome (79.1%),
which was polarized toward ompC gene, encoding proteins
recently reported to possess restrictive transmembrane channels
(James et al., 2009). On the other hand, the ompF-directed
transcriptome profile was prevalent among CARB-S strains
(33.3%) suggesting that permeability was determined by
a proteins with transmembrane channels favorable for β-
lactam penetration. The second group of CARB-S strains was
characterized by a relatively unchanged OM transcriptome
profile (28.6%).
Carbapenem-susceptible E. cloacae strains served as an
important point of reference during analysis of the coexistence
of various mechanisms of resistance and their effect on the
phenotype of investigated pathogens. It is worth noting that
among CARB-S microorganisms we described individual cases
of (1) derepression of AmpC cephalosporinase (S53, S54) as
well as (2) strains demonstrating ompC-directed polarization
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TABLE 6 | Molecular characteristic of clinical E. cloacae strains.
# ampC—fold increase ompF—fold decrease ompC—fold decrease OM transcriptome profile* ESBL ST
log2FCampC FCampC log2FCompF FCompF log2FCompC FCompC
R1 [↑] 2.8 7.1 [↓] 5.68 51.3 [↑] −0.97 0.5 II – ST-89
R2 [↑] 4.5 23.3 [↓] 1.61 3.1 – 0.39 1.3 III – ST-89
R3 [↑] 2.2 4.5 [↓] 1.23 2.3 [↑] −1.97 0.3 II – ST-89
R4 – 0.2 1.2 – N/A N/A – N/A N/A N/A – ST-186
R5 [↑] 2.7 6.6 – 0.83 1.8 [↓] 1.76 3.4 V – ST-89
R6 [↑] 3.5 11.7 [↓] 2.03 4.1 – 0.60 1.5 III – ST-89
R7 [↑] 6.4 86.1 – 0.82 1.8 [↓] 2.15 4.4 V + ST-89
R8 [↑] 6.3 77.7 – 0.21 1.2 [↑] −3.19 0.1 IV – ST-89
R9 [↑] 3.3 9.7 – 0.78 1.7 [↑] −1.88 0.3 IV – ST-89
R10 [↑] 4.6 24.6 – 0.92 1.9 [↑] −1.85 0.3 IV + ST-89
R11 [↑] 4.2 18.3 [↓] 1.30 2.5 [↑] −2.38 0.2 II – ST-89
R12 [↑] 3.6 11.8 [↓] 1.81 3.5 [↑] −1.53 0.3 II – ST-89
R13 [↑] 10.0 1052.6 [↓] 2.25 4.8 [↑] −2.02 0.2 II – ST-89
R14 [↑] 4.7 25.4 – 0.41 1.3 [↑] −2.60 0.2 IV + ST-89
R15 [↑] 6.0 62.7 – 0.80 1.7 [↑] −2.23 0.2 IV – ST-89
R16 [↑] 5.0 31.7 [↓] 1.64 3.1 [↑] −2.18 0.2 II – ST-89
R17 [↑] 6.8 110.3 [↓] 3.05 8.3 [↑] −1.47 0.4 II – ST-89
R18 [↑] 2.6 6.0 [↓] 5.09 34.1 – −0.05 1.0 III – ST-329
R19 [↑] 4.1 17.0 [↓] 1.30 2.5 – 0.27 1.2 III + ST-89
R20 [↑] 8.6 391.3 [↓] 1.97 3.9 – −0.77 0.6 III – ST-750
R21 [↑] 3.9 14.5 [↓] 1.07 2.1 – 0.86 1.8 III + ST-89
R22 [↑] 3.9 15.4 [↓] 1.73 3.3 – 0.31 1.2 III + ST-89
R23 [↑] 2.2 4.7 [↓] 1.29 2.4 – 0.54 1.5 III + ST-89
R24 [↑] 4.7 25.5 [↓] 3.52 11.5 [↑] −0.98 0.5 II – ST-89
R25 [↑] 7.0 132.5 [↓] 4.01 16.1 [↑] −1.52 0.3 II – ST-89
R26 [↑] 4.8 27.2 [↓] 1.32 2.5 – 0.71 1.6 III + ST-89
R28 [↑] 6.3 79.36 – −0.12 0.9 [↑] −1.86 0.3 IV + ST-89
R29 [↑] 5.2 37.32 [↑] −2.18 0.2 [↑] −1.45 0.4 VIII + ST-89
R30 [↑] 4.6 24.07 – 0.16 1.1 – −0.45 0.7 VI – ST-89
R31 [↑] 2.5 5.53 – 0.88 1.8 – −0.92 0.5 VI – ST-89
R32 [↑] 9.8 921.05 – 0.84 1.8 [↓] 1.65 3.1 V – ST-751
R33 [↑] 5.3 40.03 – 0.13 1.1 [↑] −2.29 0.2 IV – ST-89
R34 [↑] 3.5 11.01 [↓] 1.03 2.0 [↑] −2.04 0.2 II – ST-89
R35 [↑] 4.0 15.91 – 0.92 1.9 [↑] −1.03 0.5 IV + ST-89
R36 [↑] 4.1 17.21 – 0.78 1.7 [↑] −1.72 0.3 IV + ST-89
R37 [↑] 3.8 13.87 [↓] 1.00 2.0 – −0.63 0.6 III + ST-89
R38 [↑] 9.4 692.77 [↓] 3.68 12.8 [↓] 1.83 3.6 I – ST-89
R39 [↑] 4.0 15.89 – 0.83 1.8 [↑] −1.73 0.3 IV – ST-89
R40 [↑] 4.7 26.10 [↓] 2.17 4.5 [↑] −1.09 0.5 II – ST-89
R41 [↑] 4.1 16.62 – 0.67 1.6 [↑] −1.40 0.4 IV + ST-89
R42 [↑] 5.0 31.70 – 0.68 1.6 [↑] −1.65 0.3 IV + ST-89
R43 [↑] 2.9 7.34 – 0.81 1.8 – −0.63 0.6 VI + ST-121
R44 [↑] 5.7 51.08 – 0.27 1.2 – −0.89 0.5 VI + ST-89
R69 [↑] 2.7 7.25 [↓] 2.26 4.8 – −0.87 0.5 III + ST-89
S45 – 0.08 1.06 – 0.32 1.3 [↑] −2.39 0.2 IV – ST-335
S46 – 0.96 1.94 [↓] 1.34 2.5 [↑] −2.23 0.2 II + ST-335
S47 – 0.50 1.41 – 0.29 1.2 [↑] −1.15 0.5 IV + ST-110
S48 – 0.21 1.16 – 0.16 1.1 – −0.05 1.0 VI + ST-133
S49 – 1.41 2.66 [↑] −1.14 0.5 – −0.25 0.8 IX + ST-90
S52 – −0.42 0.75 – 0.75 1.7 – −0.24 0.8 VI + ST-407
(Continued)
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TABLE 6 | Continued
# ampC—fold increase ompF—fold decrease ompC—fold decrease OM transcriptome profile* ESBL ST
log2FCampC FCampC log2FCompF FCompF log2FCompC FCompC
S53 [↑] 2.24 4.72 [↑] −1.76 0.3 [↓] 5.35 40.8 VII – ST-168
S54 [↑] 3.00 8.02 [↑] −3.15 0.1 [↓] 4.22 18.6 VII – ST-68
S55 – 1.88 3.68 – −0.62 0.7 [↑] −1.57 0.3 IV – ST-79
S56 – 1.90 3.73 – −0.93 0.5 [↓] 7.22 149.3 V – ST-168
S57 – 0.28 1.21 – 0.02 1.0 – −0.80 0.6 VI – ST-752
S58 – 1.16 2.23 – 0.44 1.4 [↓] 0.99 2.0 V – ST-108
S59 – 0.17 1.13 – −0.57 0.7 – −0.18 0.9 VI – ST-45
S61 – 0.25 1.19 – 0.87 1.8 [↓] 1.04 2.1 V + ST-754
S62 – 0.73 1.66 [↓] 4.02 16.3 – 0.06 1.0 III – ST-89
S63 – 0.90 1.86 – 0.20 1.2 [↓] 1.28 2.4 V + ST-133
S64 – 0.29 1.23 – 0.35 1.3 – 0.12 1.1 VI – ST-78
S65 – 0.64 1.55 – 0.23 1.2 – 0.37 1.3 VI + ST-753
S66 – 1.32 2.50 [↓] 2.05 4.1 – 0.55 1.5 III + ST-133
S67 – 0.78 1.71 [↓] 2.31 5.0 [↓] 5.19 36.6 I + ST-108
S68 – 0.57 1.48 – −0.46 0.7 [↑] −1.08 0.5 IV – ST-45
Strains R3 and R4 possessed blaOXA−48 carbapenemase; Arrows represents up− and down−regulation of particular transcripts.
*Detailed characteristics of OM transcriptome profiles is available in Table 2.
of OM transcriptome. However, it must be emphasized that
there was no co-occurrence of the aforementioned mechanisms.
Moreover, overproduction of AmpC enzyme in S53 and S54 was
compensated by ompF-directed OM transcriptome polarization.
OM permeability of those two strains was determined by
porin with a relatively large transmembrane domain, wherein
the electrostatic potential and molecular configuration allows
efficient penetration of β-lactam antimicrobials into periplasmic
space. We described another unique strain among the CARB-
S subpopulation, S62-ST89 which was sequence type dominant
in group resistant to carbapenems. However, strain S62 stood
out in terms of molecular characteristics—the tested strain did
not develop carbapenem-resistance despite the decrease in ompF
expression and ompC-directed OM transcriptome polarization.
Low-level AmpC expression was the distinguishing feature of
strain S62-ST89.
It seems that co-operation among different mechanisms
is crucial for exhibiting carbapenem resistance in clinical
aspects. Carbapenems are “poor substrates” in relation to
most chromosomal and plasmidic AmpC-type isoenzymes
(Mammeri et al., 2008, 2010; Jacoby, 2009). However, an
increase of carbapenem MIC is often a result of decreased
permeability of the OM in conjunction with a significant
increase in AmpC expression level and/or mutations affecting the
hydrolytic properties of chromosomal β-lactamase. Interestingly,
development of clinical resistance conditioned by classical
carbapenemases, in many cases also requires an additional
mechanism of resistance, e.g., decreased OM permeability. The
results obtained by many authors pointed to a slight increase
of carbapenem MICs among strains presenting an isolated
resistance mechanism—including KPC, IMP, OXA-48, and VIM-
type acquired carbapenemases (Cuzon and Naas, 2008; Carrër
et al., 2010; Cuzon et al., 2011; Daikos andMarkogiannakis, 2011;
Poirel et al., 2012). Based on low MIC values of carbapenems,
evaluated pathogens were often categorized as sensitive or
intermediate in relation to particular agents (Yan et al., 2001;
Daikos et al., 2009; Endimiani et al., 2009; Hirsch and Tam, 2010;
Kumarasamy et al., 2010; Picão et al., 2013).
Research papers analyzing the impact of permeability
disturbances on carbapenem-resistance phenotype development
in Gram-negative bacteria showed a great variety of possible
OM transcriptome profiles. The decrease of gene expression may
cover an isolated decrease of ompC or ompF porin encoding
genes, as well as, both major OM proteins (Bialek et al., 2010).
Expression level of genes encoding OM proteins is of key
importance in case of β-lactam activity, as demonstrated in a
study by Doménech-Sánchez et al. (2003) on K. pneumoniae
strain CSUB10R, which lost both OmpF, and OmpC proteins.
Complementation studies showed significant reduction of β-
lactam MIC values in strains with restored OmpF protein.
Complemented strain represented an 8-fold decrease in MIC
values of imipenem and a 128-fold decrease of cephalosporins
and meropenem MIC values. Another project emphasizing key
role of OmpF protein was published byMoya-Torres et al. (2014).
Authors performed molecular characterization of permeability
disorders in Serratia marcescens, and proved that OmpF protein
was the most important factor contributing to changes in MIC
values of β-lactams.
The results of the research work published by Babouee Flury
et al. (2016) on the development of carbapenem-resistance in
E. cloacae proved a significant contribution of the chromosomal
AmpC cephalosporinase overproduction coupled with impaired
OM permeability. The authors linked permeability disorders
with relative decrease of gene expression and/or mutations
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FIGURE 2 | Genetic relatedness of CARB-R and CARB-S E. cloacae strains. Carbapenem-resistant and carbapenem-susceptible strains has been represented
by red and green segments, respectively. Resolution of individual nodes in the phylogenetic tree represents the number of strains belonging to a particular ST. The
number of strains attributable to a particular ST is also indicated by the division of each node into the proper amount of segments. Genetic distance between different
STs is reflected by the numerical values posted at the branches of the phylogenetic tree.
in the structural porin-encoding genes. Nucleotide sequence
analysis of genes encoding OmpC and OmpF OM proteins
showed the presence of nonsense mutations and deletions
within the structural region as well as the presence of insertion
sequences disrupting promoters responsible for porin expression.
Carbapenem-resistant strains showed a 10–40-fold relative
increase in the level of ampC transcripts. In this study we
described a relative increase in AmpC cephalosporinase gene
expression among CARB-R strains; however, the range of
values was ranked from 4.5-fold increase up to expression
1000-fold higher than that of the reference strain. Analysis
of relative changes in porin-encoding gene expression level
carried out by Babouee Flury et al. (2016) showed a 2.5-fold
decrease in ompF level, and a 3-fold decrease in the ompC
expression level. The extremely low ompC expression described
by the authors amounted to a 160-fold decrease in relation to
the reference strain. In this study we described carbapenem-
resistance associated with relative decrease of ompF expression
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with the extreme value of the 50-fold reduction in transcript
levels. Another phenomenon described in this study is the shift in
the OM porin profile. Carbapenem-resistant E. cloacae showed a
tendency to compensatory increase of ompC expression.
In accordance with our results, research work published by
Szabó et al. (2006) indicated the involvement of 50-fold decrease
in ompF gene expression in carbapenem-resistant E. cloacae.
The research project published by Pérez et al. (2007) concerning
carbapenem-resistant E. cloacae was based on the analysis of
ompF and ompC gene expression levels. The authors described
decreased expression of both ompF (5-fold) and ompC (500-fold)
genes in resistant strains. The decrease in expression level of both
major OM proteins was also recorded in the report published by
Koyano et al. (2013), Philippe et al. (2015) and Jaskulski et al.
(2013).
Molecular analysis of E. aerogenes exhibiting high MIC of
imipenem (8mg/L) carried out by Fernández-Cuenca et al.
(2006) showed two coexisting mechanisms of resistance, a
decrease in expression of OM protein (40 kDa) coupled with high
AmpC activity. The report prepared by Doumith et al. (2009) was
based on molecular analysis of resistance to ertapenem among
Enterobacter spp., and Klebsiella spp. isolated in the UK. The
coexistence of enzymatic barrier (AmpC overexpression or KPC
carbapenemase) in conjunction with impaired permeability of
OM was found to be the main cause of ertapenem resistance in
E. cloacae. Depending on the degree of resistance to ertapenem,
the authors observed various OM protein profiles—a decrease in
expression of both major porins, or isolated decrease in ompF
expression while maintaining ompC gene function.
Analysis of ertapenem-resistance in E. cloacae isolated in
Taiwan indicated the possible participation of active eﬄux,
AmpC derepression, and impaired permeability of OM (Yang
et al., 2012). Acquired carbapenemase IMP-8 was detected in
5% of resistant strains, coinciding with the results of this study.
Changes in porin-encoding gene expression were observed in
43.4% of strains with various porin genotypes. The largest
percentage of resistant E. cloacae showed impaired permeability
caused by a decrease in ompF expression level.
Analysis of the basic requirements for the development of
carbapenem resistance among E. cloacae strains isolated in
China indicated the coexistence of derepressed chromosomal
AmpC β-lactamase, a decrease in ompF expression, and the
presence of acquired VIM-2 carbapenemase in individual strains
(Lee et al., 2012). In the case of Enterobacter spp. isolated
in Chile, among different levels of carbapenem resistance, the
authors described coexistence of impaired OM permeability with
AmpC overexpression (Wozniak et al., 2012). We described
single strains (R30, R31, R43, and R44) presenting relatively
unchanged porin profile, which were resistant to ertapenem
(MIC values from 2 to 8mg/L). Ertapenem resistance in those
E. cloacae strains was probably associated with considerable
AmpC overexpression.
In a report published by Novais et al. (2012) considering
ertapenem resistance in Enterobacteriaceae, the authors
indicated two mechanisms of OM permeability disruption,
namely, nonsense mutations and/or insertion sequence (IS)
incorporation into structural porin-encoding genes, and
production of nonfunctional proteins effecting from mutations
in the third loop region of the transmembrane channel. Reuter
et al. (2013) reported a frame shift and/or stop codon presence
in the ompF gene of resistant pathogens. Goessens et al. (2013)
showed that a decreased expression of two major OM proteins
may not lead to the development of carbapenem resistance. In
accordance with this finding, we described the case of a single
strain, S67, showing a relatively decreased expression of both
ompF and ompC, which retained susceptibility to carbapenems
despite coexistent ESBL production. Relatively increased
ertapenem MIC (0.125mg/L) was the only characteristic feature
of strain S67.
Alterations of OM protein balance (OmpF/OmpC) in the
context of β-lactam resistance development have not been
widely reported in the literature. However, there are numerous
reports indicating porin balance regulatory cascade as an
adaptive mechanism of Enterobacteriaceae and other Gram-
negative rods, utilized in response to adverse environmental
conditions such as, high osmotic pressure or changes in the
availability of oxygen (Nikaido, 2003; Ruiz et al., 2006; Vogel
and Papenfort, 2006). It is possible for microorganisms to
regulate the OmpF-OmpC ratio, thereby choosing porins
with preferable transmembrane channel diameter, electrostatic
potential, and the molecular configuration inside the channel.
Regulatory cascades can also allow pathogens to take over
permeability by the minor porins such as OmpY or OmpK37
(Knopp and Andersson, 2015; Bystritskaya et al., 2016). Various
regulatory cascades can be launched in response to changing
environmental conditions. Among possible mechanisms
involved in decreasing OM permeability due to OmpC-directed
OM porin balance, we can mention the increased expression
of bolA morphogene responsible for adaptive stress response
in Enterobacteriaceae (Freire et al., 2006), and the TolC,
LamB, and Dps proteins which can significantly influence
OM protein network (Yang et al., 2011). Handling of the OM
protein balance according to environmental factors may also be
conditioned by the two-component regulatory system OmpR-
EnvZ (Chhabra et al., 2012; Shimada et al., 2015). Another
mechanism influencing the relationship between produced
OM proteins is a two-component system CpxA-CpxR closely
associated with the activity of the AtpB protein, the β-subunit
of ATP synthase localized in the plasma membrane (Lin et al.,
2012). Studies conducted by Batchelor et al. (2005) based
on controlled mutagenesis showed that phosphorylation of
the CpxR regulator in “wild-type” strains activates histidine
kinase CpxA, and leads to transient polarization of OM
protein balance in response to environmental stress. Moreover,
the authors proved that mutations within histidine kinase
CpxA showed the possible fixation of OmpC-directed OM
polarization. It can be assumed that factors disturbing the
physiological regulatory cascade may be associated with
consistent OM protein balance polarization toward OmpC
with restrictive channel or abnormal expression of both major
porins (Malickbasha et al., 2010; Yang et al., 2011; Tängdén et al.,
2013).
Molecular analysis of E. aerogenes strains isolated during
imipenem treatment revealed the potential role of ompC-directed
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OM protein polarization (Lavigne et al., 2012). Analyzed strains
with permeability disturbances were characterized by resistance
to ertapenem, and elevated MIC values of imipenem. Moreover,
the authors described strains that lost both OmpF and OmpC
proteins, and developed resistance to imipenem in the clinical
aspect. Studies on the expression profile of porin-encoding genes
amongMDRK. pneumoniae performed byHasdemir et al. (2004)
showed interdependence between two major porins. For most
analyzed MDR microorganisms loss of OmpF expression was
accompanied with the retained production of the OmpC protein
conditioning permeability of the OM.
Recently published reports indicated a high incidence of
carbapenem-resistant Enterobacteriaceae without participation
of any acquired carbapenemase. The authors indicated
comorbidity of OM permeability disorders with the presence of
AmpC and/or extended-spectrum β-lactamases (Hasdemir et al.,
2004; Drew et al., 2013; Ammenouche et al., 2014). Acquired
carbapenemase participation in the development of resistance
to carbapenems among Enterobacteriaceae was estimated in a
report published by Robert et al. (2014). The analyses included
pathogens resistant to at least one carbapenem isolated primarily
from urinary and respiratory tracts of patients hospitalized in
71 medical centers in France. Carbapenem-resistant E. cloacae
strains, the subject of this paper, were also obtained in the
largest proportion from the urinary and respiratory tracts. In
the aforementioned report, E. cloacae were the predominant
pathogen (58.2%), and resistance to carbapenems was not
conditioned by the presence of acquired carbapenemases.
Among all microorganisms subjected to molecular analysis,
only 12.6% of carbapenem-resistant strains possessed acquired
carbapenemases. In the case of the remaining pathogens,
resistance was associated with impaired OM permeability.
Here we report the co-operation of three distinct carbapenem-
resistance mechanisms—production of OXA-48 carbapenemase,
AmpC overproduction, and alterations in outer membrane
(OM) transcriptome balance. Carbapenem-resistant E. cloacae
subpopulations were characterized by (1) downregulation
of ompF gene, which encodes protein with extensive
transmembrane channels, and (2) the polarization of OM
transcriptome-balance, which was sloped toward ompC gene,
encoding proteins recently reported to possess restrictive
transmembrane channels. The growing prevalence of pathogens
resistant to most or even all currently available antimicrobial
agents heralds the potential risk of a future “post-antibiotic era”
(Falagas and Bliziotis, 2007; Livermore, 2009; Hornsey et al.,
2010; Chen et al., 2011; Bergen et al., 2012; Diena et al., 2012;
Majewski et al., 2012, 2014b; Yahav et al., 2012; Linkevicius
et al., 2013; Veleba et al., 2013; Deng et al., 2014). Great effort
needs to be taken to explore the background of resistance to
antimicrobials of “last-resort.”
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